spacer
home > directory > Alfasigma
PHARMACEUTICAL INDUSTRY DIRECTORY

Alfasigma

Alfasigma
 Alfasigma is one of the leading Italian pharmaceutical company, focused on prescription drugs, self-medication and nutraceutical products. Established in 2015, after the merge of Alfa Wassermann and Sigma-Tau, today it is present with branches and distributors in around 90 countries worldwide.

In 2018 Alfasigma exceeded 1 billion Euro of turnover, half of which generated by foreign markets.

Alfasigma’s strategy is based on three guidelines which, over the years, have assured the group constant and balanced growth: Research, Technology and Internationalization.

Implementing research and technology to constantly improve its products, opening up new frontiers, extending to new markets.

During the years it has invested heavily in plant and human resources and currently has over 2,800 employees and five manufacturing plants covering almost 500,000 square metres.

As a result of the last investments, two new sterile departments for sterile powder and pre-filled syringes will become fully operational in 2020. The first, will be dedicated to the production of vials filled with sterile powders and liquids.

Attention to quality is a high priority for Alfasigma and the standards it applies comply with FDA, ANVISA, GCC, PMDA and EUGMP requirements.
email contractmanufacturing@alfasigma.com
web manufacturing.alfasigma.com
email Alfasigma S.p.A. Alanno (PE), Via E.Fermi, 1 Pomezia (RM), Via Pontina, km 30,400
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st – 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement